Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The carotid sinus baroreceptor is a specialized stretch-sensitive mechanoreceptor located in the dilation (sinus) at the bifurcation of the common carotid artery and proximal internal carotid artery[1][4][7]. It consists of nerve endings embedded in the vessel wall that detect changes in blood pressure by sensing arterial wall stretch. These baroreceptors relay afferent signals through the carotid sinus nerve, a branch of the glossopharyngeal nerve (cranial nerve IX), to the central nervous system, primarily the nucleus tractus solitarius in the medulla. Their physiological role is to provide rapid, moment-to-moment feedback regulation of blood pressure and heart rate via the baroreflex arc, modulating autonomic output to the heart and blood vessels. Dysfunction or hypersensitivity of the carotid sinus baroreceptor is implicated in conditions such as hypertension, syncope, and carotid sinus syndrome[1][3][4][7]. Carotid sinus baroreceptors are now targeted therapeutically in drug-resistant hypertension and heart failure by devices that stimulate these receptors to shift autonomic balance and lower blood pressure[3][6]. Additional details: - There are two main types: Type 1 (dynamic, large myelinated fibers) and Type 2 (tonic, small/myelinated and unmyelinated fibers). Both are sensitive to high arterial pressure[1][7][8]. - Interventional devices to stimulate these receptors remain investigational or are used under specific regulatory exemptions due to limited efficacy and safety data[6]. - The baroreflex they modulate can be both beneficial (as in pharmacological or device therapy for hypertension) and potentially hazardous when excessively stimulated (leading to vasovagal syncope or carotid sinus hypersensitivity)[3][6][7].
Mechanical or electrical stimulation modulates baroreceptor activity, leading to decreased sympathetic tone and reduced blood pressure; baroreflex activation therapy reduces sympathetic activity and increases parasympathetic tone to lower blood pressure[3][6][4]
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Carotid sinus baroreceptor.